Remote Working

Med Communications has a high percentage of workers who normally work from their own home offices. We believe this allows us to get the best people for the job and offers the benefit of work-life balance to our employees. At this time, close to 100% of Med Comm staff is now working at home, and we have continued to provide seamless support to our clients while ensuring the safety of our staff during this difficult time.

So, how do we do it? As far as tools,

We are here for you

During these complex and trying times, we are here for you, the client, the patient, and each other. If your company is in need of additional support in medical call center, medical writing, or pharmacovigilance, please contact us to discuss how we can support you.

Med Communications will continue to remain open, ensuring uninterrupted support to our biopharmaceutical company partners who are working diligently to develop treatments all around the globe.

In our family of team members, our first priority is the well-being of our employees, our

Need High-quality, Timely, and Accurate Scientific Information?

At Med Communications, we specialize in presenting high-quality, timely, and accurate scientific information, so we appreciate getting facts from scientific experts. If you’re looking for high-quality and accurate scientific information about the current state of COVID-19, we’ve assembled some resources:

  • The US Centers for Disease Control and Prevention has a page summarizing the situation, with information for certain populations as well as individuals: https://www.cdc.gov/coronavirus/2019-ncov/index.html
  • The World Health Organization has videos and images to share on social media about how to protect yourself, “myth-busters,” and

DIA Medical Affairs and Scientific Communications Forum

The DIA Medical Affairs and Scientific Communications Forum has been moved to May 6-7, 2020 and will be a virtual event, with both speakers and attendees participating remotely via a digital platform. But the preconference Medical Communications Primer: Fundamentals of Medical Communication will still be taking place on Sunday, March 22. Our Director of Medical Communications, Ellen Whipple, will be participating as an instructor as she has for many years. There’s still time to register for the main conference, and Med Communications will be there.

If

DIA Medical Affairs and Scientific Communications Forum

Are you attending the DIA Medical Affairs and Scientific Communications Forum next week? You’ve probably heard it’s gone virtual, but for our Director of Medical Communications, Ellen Whipple, the show must go on!

As she has for many years, she will participate as an instructor for the Medical Communications Primer: Fundamentals of Medical Communication during the preconference sessions on Sunday, March 22. She will also be part of a session called A Whole New World: Real World Evidence (RWE) on March 24 (9:10 – 10:25 am

AMCP Format for Formulary Dossiers Series – Table of Highlights for Unapproved Products

The formats for Unapproved Product and Unapproved Use Dossiers are new with the latest AMCP Format for Formulary Dossiers. Because manufacturers cannot make claims about an unapproved product or use, the Unapproved Product Sections Dossiers have a Highlights and Overview section instead of an Executive Summary detailing the clinical and economic value of the product, The recommended length of the Highlights and Overview section is 2 pages (4 pages max), and it is recommended that much of the information be presented in a Table Of

AMCP Format for Formulary Dossiers Series – Similarities and Differences in Each Section of Each Type of Dossier

While there are some similarities between the sections in the Approved Product Dossiers and the Unapproved Product and Unapproved Use Dossiers, there are many differences. Section 1 provides a different experience in the Approved Product Dossier than the Unapproved Product and Unapproved Use Dossiers because of the limited data that can be shared before a product is approved. Sections 2 and 3 in all dossiers have similar headings and information, but Sections 4, 5, and 6 don’t even exist in the Unapproved Product and Unapproved

Medical Affairs Professional Society (MAPS) Annual Meeting

The 3-day Medical Affairs Professional Society (MAPS) Annual Meeting is March 8-11 in Miami Beach, FL, and Business Development Manager Stacy Witham will be attending. This meeting always has relevant workshops, and it’s a great opportunity to catch up with Medical Affairs peers.

If you’ll be there, set up some time to discuss our Medical Affairs offerings with Stacy: stacy.witham@medcomminc.com or 877-477-0977.

#medicalaffairs #networking

AMCP Format for Formulary Dossiers Series – Recommendations

While many organizations follow the AMCP Format for Formulary Submissions, it is only a guidance, not a mandate, for how manufacturers and health care decision-makers can act in the process of requesting and providing clinical and economic information and evidence on new products. Some of the recommendations provided within the AMCP Format for Formulary Submissions are provided in the image.

Check back for more information on changes in the new AMCP Format for Formulary Submissions. If you need any assistance with adjusting your dossiers to meet